{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:38:50Z","timestamp":1795034330116,"version":"4.10.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myeloid-derived growth factor (MYDGF) is a paracrine-acting protein that is produced by bone marrow-derived monocytes and macrophages to protect and repair the heart after myocardial infarction (MI). This effect can be used for the development of protein-based therapies for ischemic tissue repair, also beyond the sole application in heart tissue. Here, we report the X-ray structure of MYDGF and identify its functionally relevant receptor binding epitope. MYDGF consists of a 10-stranded \u03b2-sandwich with a folding topology showing no similarities to other cytokines or growth factors. By characterizing the epitope of a neutralizing antibody\u00a0and utilizing functional assays to study the activity of surface patch-mutations, we were able to localize the receptor interaction interface to a region around two surface tyrosine residues 71 and 73 and an adjacent prominent loop structure of residues 97\u2013101. These findings enable structure-guided protein engineering to develop modified MYDGF variants with potentially improved properties for clinical use.<\/jats:p>","DOI":"10.1038\/s41467-019-13343-7","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T06:03:15Z","timestamp":1574748195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Crystal structure and receptor-interacting residues of MYDGF \u2014 a protein mediating ischemic tissue repair"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4304-7434","authenticated-orcid":false,"given":"Rebecca","family":"Ebenhoch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Akhdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Reboll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortimer","family":"Korf-Klingebiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6483-3069","authenticated-orcid":false,"given":"Priyanka","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Frego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Rybina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Miglietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Pekcec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai C.","family":"Wollert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"13343_CR1","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1606915","volume":"376","author":"JL Anderson","year":"2017","unstructured":"Anderson, J. L. & Morrow, D. A. Acute myocardial infarction. N. Engl. J. Med. 376, 2053\u20132064 (2017).","journal-title":"N. Engl. J. Med."},{"key":"13343_CR2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0140-6736(08)61237-4","volume":"372","author":"HD White","year":"2008","unstructured":"White, H. D. & Chew, D. P. Acute myocardial infarction. Lancet 372, 570\u2013584 (2008).","journal-title":"Lancet"},{"key":"13343_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0735-1097(01)01711-9","volume":"39","author":"RJ Burns","year":"2002","unstructured":"Burns, R. J. et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J. Am. Coll. Cardiol. 39, 30\u201336 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"13343_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nm.3778","volume":"21","author":"M Korf-Klingebiel","year":"2015","unstructured":"Korf-Klingebiel, M. et al. Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction. Nat. Med. 21, 140\u2013149 (2015).","journal-title":"Nat. Med."},{"key":"13343_CR5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIRCRESAHA.113.300215","volume":"113","author":"SM Jay","year":"2013","unstructured":"Jay, S. M. & Lee, R. T. Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair. Circ. Res. 113, 933\u2013943 (2013).","journal-title":"Circ. Res."},{"key":"13343_CR6","doi-asserted-by":"publisher","first-page":"13166","DOI":"10.1074\/jbc.AC118.002052","volume":"293","author":"V Bortnov","year":"2018","unstructured":"Bortnov, V. et al. Myeloid-derived growth factor is a resident endoplasmic reticulum protein. J. Biol. Chem. 293, 13166\u201313175 (2018).","journal-title":"J. Biol. Chem."},{"key":"13343_CR7","doi-asserted-by":"publisher","first-page":"W6","DOI":"10.1093\/nar\/gkl164","volume":"34","author":"J Ye","year":"2006","unstructured":"Ye, J., McGinnis, S. & Madden, T. L. BLAST: improvements for better sequence analysis. Nucleic Acids Res. 34, W6\u2013W9 (2006).","journal-title":"Nucleic Acids Res."},{"key":"13343_CR8","doi-asserted-by":"publisher","first-page":"W244","DOI":"10.1093\/nar\/gki408","volume":"33","author":"J Soding","year":"2005","unstructured":"Soding, J., Biegert, A. & Lupas, A. N. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res. 33, W244\u2013W248 (2005).","journal-title":"Nucleic Acids Res."},{"key":"13343_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41587-019-0036-z","volume":"37","author":"JJ Almagro Armenteros","year":"2019","unstructured":"Almagro Armenteros, J. J. et al. SignalP 5.0 improves signal peptide predictions using deep neural networks. Nat. Biotechnol. 37, 420\u2013423 (2019).","journal-title":"Nat. Biotechnol."},{"key":"13343_CR10","doi-asserted-by":"publisher","first-page":"D161","DOI":"10.1093\/nar\/gkp885","volume":"38","author":"CJ Sigrist","year":"2010","unstructured":"Sigrist, C. J. et al. PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res. 38, D161\u2013D166 (2010).","journal-title":"Nucleic Acids Res."},{"key":"13343_CR11","doi-asserted-by":"publisher","first-page":"D493","DOI":"10.1093\/nar\/gkx922","volume":"46","author":"I Letunic","year":"2018","unstructured":"Letunic, I. & Bork, P. 20 years of the SMART protein domain annotation resource. Nucleic Acids Res. 46, D493\u2013D496 (2018).","journal-title":"Nucleic Acids Res."},{"key":"13343_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/protein\/6.3.233","volume":"6","author":"EG Hutchinson","year":"1993","unstructured":"Hutchinson, E. G. & Thornton, J. M. The Greek key motif: extraction, classification and analysis. Protein Eng. Des. Sel. 6, 233\u2013245 (1993).","journal-title":"Protein Eng. Des. Sel."},{"key":"13343_CR13","doi-asserted-by":"publisher","first-page":"26161","DOI":"10.1074\/jbc.M109.024067","volume":"284","author":"MA Higgins","year":"2009","unstructured":"Higgins, M. A. et al. Differential recognition and hydrolysis of host carbohydrate antigens by Streptococcus pneumoniae family 98 glycoside hydrolases. J. Biol. Chem. 284, 26161\u201326173 (2009).","journal-title":"J. Biol. Chem."},{"key":"13343_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1089\/jir.2006.26.866","volume":"26","author":"H Schmeisser","year":"2006","unstructured":"Schmeisser, H. et al. Binding characteristics of IFN-alpha subvariants to IFNAR2-EC and influence of the 6-histidine tag. J. Interferon Cytokine Res. 26, 866\u2013876 (2006).","journal-title":"J. Interferon Cytokine Res."},{"key":"13343_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature26153","volume":"556","author":"G Scapin","year":"2018","unstructured":"Scapin, G. et al. Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis. Nature 556, 122\u2013125 (2018).","journal-title":"Nature"},{"key":"13343_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0092-8674(02)00963-7","volume":"110","author":"H Ogiso","year":"2002","unstructured":"Ogiso, H. et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110, 775\u2013787 (2002).","journal-title":"Cell"},{"key":"13343_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1073\/pnas.93.1.7","volume":"93","author":"DR Davies","year":"1996","unstructured":"Davies, D. R. & Cohen, G. H. Interactions of protein antigens with antibodies. Proc. Natl Acad. Sci. USA 93, 7\u201312 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"13343_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/prot.340070203","volume":"7","author":"EA Padlan","year":"1990","unstructured":"Padlan, E. A. On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands. Proteins 7, 112\u2013124 (1990).","journal-title":"Proteins"},{"key":"13343_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/0959-440X(94)90267-4","volume":"4","author":"IA Wilson","year":"1994","unstructured":"Wilson, I. A. & Stanfield, R. L. Antibody-antigen interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 4, 857\u2013867 (1994).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"13343_CR20","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1182\/blood-2008-04-144758","volume":"112","author":"G Stoll","year":"2008","unstructured":"Stoll, G., Kleinschnitz, C. & Nieswandt, B. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood 112, 3555\u20133562 (2008).","journal-title":"Blood"},{"key":"13343_CR21","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/ar2145","volume":"9","author":"T Weiler","year":"2007","unstructured":"Weiler, T. et al. The identification and characterization of a novel protein, c19orf10, in the synovium. Arthritis Res. Ther. 9, R30 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"13343_CR22","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1016\/S0021-9258(18)68146-3","volume":"263","author":"MJ Knauf","year":"1988","unstructured":"Knauf, M. J. et al. Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers. J. Biol. Chem. 263, 15064\u201315070 (1988).","journal-title":"J. Biol. Chem."},{"key":"13343_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24897-9","volume":"8","author":"M Kuna","year":"2018","unstructured":"Kuna, M., Mahdi, F., Chade, A. R. & Bidwell, G. L. 3rd Molecular size modulates pharmacokinetics, biodistribution, and renal deposition of the drug delivery biopolymer elastin-like polypeptide. Sci. Rep. 8, 7923 (2018).","journal-title":"Sci. Rep."},{"key":"13343_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/febs.12056","volume":"280","author":"R Tlatli","year":"2013","unstructured":"Tlatli, R. et al. Grafting of functional motifs onto protein scaffolds identified by PDB screening\u2013an efficient route to design optimizable protein binders. FEBS. J. 280, 139\u2013159 (2013).","journal-title":"FEBS. J."},{"key":"13343_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.tibtech.2005.07.007","volume":"23","author":"T Hey","year":"2005","unstructured":"Hey, T., Fiedler, E., Rudolph, R. & Fiedler, M. Artificial, non-antibody binding proteins for pharmaceutical and industrial applications. Trends Biotechnol. 23, 514\u2013522 (2005).","journal-title":"Trends Biotechnol."},{"key":"13343_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep41212","volume":"7","author":"H Yu","year":"2017","unstructured":"Yu, H., Yan, Y., Zhang, C. & Dalby, P. A. Two strategies to engineer flexible loops for improved enzyme thermostability. Sci. Rep. 7, 41212 (2017).","journal-title":"Sci. Rep."},{"key":"13343_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1107\/S0907444911007773","volume":"67","author":"C Vonrhein","year":"2011","unstructured":"Vonrhein, C. et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D Biol. Crystallogr. 67, 293\u2013302 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"13343_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"13343_CR29","unstructured":"Tickle, I. J. et al. STARANISO (Global Phasing Ltd., Cambridge, United Kingdom, 2018)."},{"key":"13343_CR30","first-page":"215","volume":"364","author":"C Vonrhein","year":"2007","unstructured":"Vonrhein, C., Blanc, E., Roversi, P. & Bricogne, G. Automated structure solution with autoSHARP. Methods Mol. Biol. 364, 215\u2013230 (2007).","journal-title":"Methods Mol. Biol."},{"key":"13343_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/978-1-4939-7000-1_15","volume":"1607","author":"A Thorn","year":"2017","unstructured":"Thorn, A. Experimental phasing: substructure solution and density modification as implemented in SHELX. Methods Mol. Biol. 1607, 357\u2013376 (2017).","journal-title":"Methods Mol. Biol."},{"key":"13343_CR32","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"13343_CR33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1107\/S0907444911056058","volume":"68","author":"OS Smart","year":"2012","unstructured":"Smart, O. S. et al. Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER. Acta Crystallogr. D Biol. Crystallogr. 68, 368\u2013380 (2012).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"13343_CR34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"13343_CR35","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1021\/acs.analchem.9b01325","volume":"91","author":"TS Hageman","year":"2019","unstructured":"Hageman, T. S. & Weis, D. D. Reliable identification of significant differences in differential hydrogen exchange-mass spectrometry measurements using a hybrid significance testing approach. Anal. Chem. 91, 8008\u20138016 (2019).","journal-title":"Anal. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13343-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13343-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13343-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T21:19:15Z","timestamp":1671225555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13343-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["13343"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-13343-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"13 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.E., P.G., J.A., Y.H., L.F., I.R., J.M., A.P. and H.N. were full-time employees of Boehringer Ingelheim at the time this study was performed. M.K.-K. and K.C.W. hold a patent and entered a collaborative agreement with Boehringer Ingelheim covering the therapeutic use of MYDGF in cardiovascular disease. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5379"}}